Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes. (Q54333062)
Jump to navigation
Jump to search
scientific article published on 20 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes. |
scientific article published on 20 December 2011 |
Statements
Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes. (English)
Motoko Kanzaki
Koichi Sugiyama
Atsuko Nakatsuka
Sanae Teshigawara
Kazutoshi Murakami
Kentaro Inoue
Takahiro Terami
Akihiro Katayama
Jun Eguchi
Hisaya Akiba
Hideo Yagita
Hirofumi Makino
20 December 2011
153
2
612-620